A detailed history of Bay Harbor Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bay Harbor Wealth Management, LLC holds 501 shares of ABBV stock, worth $89,373. This represents 0.03% of its overall portfolio holdings.

Number of Shares
501
Previous 513 2.34%
Holding current value
$89,373
Previous $87,000 12.64%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$163.84 - $199.33 $1,966 - $2,391
-12 Reduced 2.34%
501 $98,000
Q2 2024

Jul 24, 2024

BUY
$154.79 - $180.76 $2,476 - $2,892
16 Added 3.22%
513 $87,000
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $639 - $728
-4 Reduced 0.8%
497 $90,000
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $275 - $309
2 Added 0.4%
501 $77,000
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $801 - $927
6 Added 1.22%
499 $74,000
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $5,035 - $6,266
-38 Reduced 7.16%
493 $66,000
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $4,916 - $5,662
-34 Reduced 6.02%
531 $84,000
Q4 2022

Jan 25, 2023

SELL
$138.31 - $165.87 $1,383 - $1,658
-10 Reduced 1.74%
565 $91,000
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $2,684 - $3,078
-20 Reduced 3.36%
575 $77,000
Q1 2022

Apr 19, 2022

SELL
$131.98 - $163.75 $19,005 - $23,580
-144 Reduced 19.49%
595 $96,000
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $12,999 - $16,447
-121 Reduced 14.07%
739 $105,000
Q3 2021

Nov 24, 2021

SELL
$106.4 - $120.78 $14,044 - $15,942
-132 Reduced 13.31%
860 $93,000
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $46,397 - $51,689
-441 Reduced 30.77%
992 $112,000
Q1 2021

May 05, 2021

SELL
$102.3 - $112.62 $42,045 - $46,286
-411 Reduced 22.29%
1,433 $155,000
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $81,858 - $110,517
-1,017 Reduced 35.55%
1,844 $198,000
Q3 2020

Oct 27, 2020

SELL
$85.91 - $100.83 $113,315 - $132,994
-1,319 Reduced 31.56%
2,861 $251,000
Q2 2020

Jul 16, 2020

SELL
$73.37 - $98.18 $67,720 - $90,620
-923 Reduced 18.09%
4,180 $410,000
Q1 2020

May 20, 2020

SELL
$64.5 - $97.79 $14,770 - $22,393
-229 Reduced 4.29%
5,103 $389,000
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $937 - $1,173
-13 Reduced 0.24%
5,332 $472,000
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $35,142 - $42,251
558 Added 11.66%
5,345 $397,000
Q2 2019

Jul 18, 2019

SELL
$65.7 - $83.98 $6,898 - $8,817
-105 Reduced 2.15%
4,787 $348,000
Q1 2019

Apr 22, 2019

BUY
$77.14 - $90.79 $57,315 - $67,456
743 Added 17.91%
4,892 $394,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $322,999 - $398,345
4,149 New
4,149 $382,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bay Harbor Wealth Management, LLC Portfolio

Follow Bay Harbor Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Harbor Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bay Harbor Wealth Management, LLC with notifications on news.